Biotech

All Articles

BioMarin halts preclinical gene treatment for heart condition

.After BioMarin conducted a spring clean of its pipe in April, the business has decided that it like...

Eisai vegetations molecular adhesive SEED along with $1.5 B biobucks deal

.Big Pharmas stay caught to the idea of molecular adhesive degraders. The most recent provider to vi...

Life science credit rating company introduces with $600M

.A brand-new global life scientific research credit scores organization, termed Symbiotic Financing,...

BMS trenches TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing yet another major bet from the Caforio period, ending an off...

Nuvation standstills wager inhibitor after thinking about phase 1 information

.After looking at period 1 data, Nuvation Biography has made a decision to halt work on its one-time...

' Medical instinct' led FDA specialists to back Zevra's uncommon condition med

.Zevra Therapies' rare illness drug seems to be to be on the path to authorization this fall after o...

Pfizer takes $230M hit after axing stopped working DMD gene therapy

.Pfizer's period 3 Duchenne muscular dystrophy (DMD) genetics treatment failing has actually gone a ...

AC Immune finds 'spots' possible in Alzheimer's drug data

.After much more than 20 years of service neurodegenerative health conditions, Swiss biotech AC Immu...

GSK drops ph. 2 HPV vaccine over absence of best-in-class prospective

.GSK has junked a stage 2 individual papillomavirus (HPV) vaccination coming from its own pipe after...

OS Treatments refiles $6M IPO to finance HER2 medicine, preclinical ADCs

.OS Therapies will definitely provide on the NYSE American supply exchange this morning via a $6.4 t...